Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[Buddhahead]

NF-kB Signalling and Chronic Inflammatory Diseases: Exploring the potential of Natural Products to Drive New Therapeutic Opportunities in Drug Discovery Today, Matthew J. Killeen, Nov 2013

Abstract Excerpt:
"Chronic inflammation has a key role in the pathogenesis of multiple diseases that represents major public health and financial concerns; including heart failure, Alzheimer's Disease, and arthritis. Nuclear Factor kappa beta (NF-kB) is a central component of inflammation. Owing to it's upstream signalling position, it is considered an attractive target for new anti-inflammatory therapeutics.

Article at:
https://www.facebook.com/137874126245637/photos/a.695406507159060.1073741826.137874126245637/695406510492393/?type=3&theater